NONovo Nordisk A/S NONOF · OTC
$38.35 -1.26% (-$0.49)
- Market cap
- 1.15T kr
- Enterprise value
- 1.24T kr
- P/E
- 9.8x
- Forward P/E
- 11.8x
- PEG
- 9.3x
- P/S
- 3.5x
- P/FCF
- 15.1x
- EV/EBITDA
- 6.9x
- ROIC
- 29.7%
- Bruto marža
- 80.7%
- Neto marža
- 35.3%
- Dividend yield
- 4.63%
- Payout ratio
- 45.6%
- Neto dolg/EBITDA
- 0.5x
- Beta
- 0.35
- Free float
- 71.0%
O podjetju
Novo Nordisk A/S is a Danish pharmaceutical company headquartered in Bagsværd, Denmark, primarily known for its innovative products and treatments for diabetes. Founded in 1923, the company has grown to become a leader in insulin products as well as medications for obesity and other chronic diseases, such as hemophilia and growth disorders. Novo Nordisk operates globally, distributing its products in over 170 countries worldwide.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Maziar Mike Doustdar
Employees
68,794
Headquarters
Bagsvaerd
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke